Toby Maher, MD, PhD, professor of clinical medicine, Keck Medicine of USC, discusses the impact of changes in lung function in patients with idiopathic pulmonary fibrosis (IPF). How does the rate of ...

The fund will normally invest at least 80% of its net assets in the ETFs that comprise the index. The index is designed to provide targeted exposure to the five ETFs that the index Provider believes ...

Familial pulmonary fibrosis represented 13% of fibrotic ILD overall, with higher proportions in IPF (18%) and unclassifiable ILD (15%) than in SARD-ILD (9%). Across diagnostic subgroups, familial ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Oral nerandomilast doses of 9 mg and 18 mg were ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Two differing nerandomilast doses were assessed against ...

SAN FRANCISCO — The investigational oral agent nerandomilast was superior to placebo at slowing the decline in forced vital capacity (FVC) among patients with progressive pulmonary fibrosis (PF), ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

First Trust Dorsey Wright Dynamic Focus 5 ETF (NASDAQ: FVC) Looking for more trade ideas? Find new trade ideas from the ZINGERNATION community.